Form 4: CareDx General Counsel's Routine Stock Transaction for Tax Obligations
Insider Transaction Report
Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported a routine disposition of 276 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
Summary
- Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc. (CDNA), reported a transaction on July 7, 2025.
- The transaction involved the disposition of 276 shares of CareDx Common Stock.
- The shares were disposed of at a price of $18.45 per share.
- This disposition was a 'F' type transaction, indicating shares were withheld by the Issuer to satisfy tax withholding obligations.
- The tax obligations arose from the vesting of restricted stock units.
- Following this transaction, Jeffrey Adam Novack beneficially owns 118,491 shares of CareDx Common Stock.
Sentiment
Score: 5
Explanation: The document reports a routine, non-discretionary transaction (tax withholding) by an insider, which is neutral in sentiment. It does not indicate any positive or negative discretionary actions or significant changes in holdings.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
This Form 4 filing details a routine insider transaction for tax purposes and does not provide broader industry context or trends. It is a standard disclosure for executive compensation and share management.
Related Party Transactions
- The disposition of shares was a transaction with the Issuer (CareDx, Inc.) to satisfy tax withholding obligations, which is a common related-party transaction for equity compensation.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in investment sentiment by the insider.
- Employees: No direct impact beyond the reporting person.
Key Dates
| Date | Description |
|---|---|
| 07/07/2025 | Date of the reported transaction (disposition of shares). |
| 07/14/2025 | Date the Form 4 was signed by Jeffrey Adam Novack. |
Keywords
CareDx, CDNA, Form 4, SEC filing, insider transaction, stock disposition, tax withholding, restricted stock units, corporate officer, Jeffrey Adam Novack
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.